New York · 2025 Regular Session · Bill
A 3973: Relates to prescription drug formulary coverage for interchangeable biologics and biosimilars
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 3973 is a bill introduced in the New York House on January 30, 2025. According to its official title, it concerns: Relates to prescription drug formulary coverage for interchangeable biologics and biosimilars. Primary sponsor: John McDonald (Democratic). It lists 4 additional sponsors. Most recent recorded action (May 7, 2026): ADVANCED TO THIRD READING CAL.450.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Relates to prescription drug formulary coverage for interchangeable biologics and biosimilars.
Sponsors
Sponsors by party (alphabetical): Democratic 3 · Republican 1 · Republican/Conservative/Independence 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| John McDonald | Primary sponsor | Democratic | House | 108 |
| Keith Brown | Co-sponsor | Republican/Conservative/Independence | House | 12 |
| Jonathan Jacobson | Co-sponsor | Democratic | House | 104 |
| Brian Manktelow | Co-sponsor | Republican | House | 130 |
| Steve Otis | Co-sponsor | Democratic | House | 91 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- ADVANCED TO THIRD READING CAL.450
- REPORTED
- REFERRED TO WAYS AND MEANS
- REPORTED REFERRED TO RULES
- REFERENCE CHANGED TO WAYS AND MEANS
- PRINT NUMBER 3973A
- AMEND AND RECOMMIT TO INSURANCE
- REFERRED TO INSURANCE